Hemithoracic Arc Radiotherapy Post Pleural Decortication

Recruiting now · Not applicable

Conditions studied: Malignant Pleural Mesothelioma

In brief

Malignant Pleural Mesothelioma is an aggressive and refractory disease , the most aggressive treatment plan offered to these patients include trimodalitiy approach with chemotherapy as the mainstay of treatment . the rationale of post operative Radiotherapy is to sterilize the post operative volume to reduce local failure meanwhile minimizing toxicities in this trial we are going to assess the safety and efficacy of Radiotherapy in Mesothelioma patients poat Pleural decortication

Key facts

Study ID

NCT06910449

Run by

Cairo University

People needed

45

Starts

2024-11-11

Expected to finish

2027-02-01

Last updated by the study team

2025-04-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Evidence of metastatic disease.
• Underwent Pleural decortication.
• Able to provide informed consent.

You may not qualify if…

• Poor pulmonary function tests.
• Recurrent or palliative cases.
• Inability to attend full course of Radiotherapy or follow up visits.

Where it is running

• national Cancer Institute Cairo university — Cairo, Fom Elkhalig, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.